Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$262.75 - $319.31 $5.7 Million - $6.93 Million
-21,705 Reduced 19.63%
88,891 $27.8 Million
Q1 2024

May 03, 2024

BUY
$268.87 - $324.56 $24,467 - $29,534
91 Added 0.08%
110,596 $31.4 Million
Q4 2023

Feb 08, 2024

SELL
$255.7 - $288.46 $6,392 - $7,211
-25 Reduced 0.02%
110,505 $31.8 Million
Q3 2023

Nov 09, 2023

SELL
$218.65 - $271.46 $411,280 - $510,616
-1,881 Reduced 1.67%
110,530 $29.7 Million
Q2 2023

Aug 07, 2023

BUY
$214.27 - $253.37 $193,485 - $228,793
903 Added 0.81%
112,411 $25 Million
Q1 2023

May 01, 2023

BUY
$225.79 - $275.2 $8.06 Million - $9.82 Million
35,697 Added 47.09%
111,508 $27 Million
Q4 2022

Feb 07, 2023

BUY
$229.03 - $291.01 $27,941 - $35,503
122 Added 0.16%
75,811 $19.9 Million
Q3 2022

Oct 25, 2022

BUY
$224.46 - $253.15 $1.19 Million - $1.34 Million
5,282 Added 7.5%
75,689 $17.1 Million
Q2 2022

Aug 08, 2022

SELL
$230.71 - $256.74 $612,073 - $681,131
-2,653 Reduced 3.63%
70,407 $17.1 Million
Q1 2022

May 06, 2022

SELL
$219.27 - $242.57 $990,661 - $1.1 Million
-4,518 Reduced 5.82%
73,060 $17.7 Million
Q4 2021

Feb 08, 2022

SELL
$198.88 - $227.6 $2.02 Million - $2.31 Million
-10,146 Reduced 11.57%
77,578 $17.5 Million
Q3 2021

Oct 28, 2021

SELL
$212.27 - $248.7 $1.64 Million - $1.92 Million
-7,726 Reduced 8.09%
87,724 $18.7 Million
Q2 2021

Jul 27, 2021

SELL
$233.58 - $259.14 $231,944 - $257,326
-993 Reduced 1.03%
95,450 $23.3 Million
Q1 2021

May 03, 2021

SELL
$221.91 - $258.6 $1.38 Million - $1.6 Million
-6,202 Reduced 6.04%
96,443 $24 Million
Q4 2020

Feb 04, 2021

SELL
$216.38 - $257.67 $1.62 Million - $1.92 Million
-7,466 Reduced 6.78%
102,645 $23.6 Million
Q3 2020

Nov 06, 2020

BUY
$234.65 - $260.95 $1.51 Million - $1.68 Million
6,454 Added 6.23%
110,111 $28 Million
Q2 2020

Aug 04, 2020

SELL
$197.81 - $242.74 $865,616 - $1.06 Million
-4,376 Reduced 4.05%
103,657 $24.4 Million
Q1 2020

Apr 27, 2020

BUY
$182.24 - $241.7 $527,402 - $699,479
2,894 Added 2.75%
108,033 $21.9 Million
Q4 2019

Feb 03, 2020

SELL
$189.21 - $243.2 $1.24 Million - $1.6 Million
-6,570 Reduced 5.88%
105,139 $25.3 Million
Q3 2019

Oct 31, 2019

SELL
$174.11 - $208.62 $1.03 Million - $1.23 Million
-5,917 Reduced 5.03%
111,709 $21.6 Million
Q2 2019

Aug 09, 2019

SELL
$166.7 - $195.41 $572,614 - $671,233
-3,435 Reduced 2.84%
117,626 $21.7 Million
Q1 2019

May 02, 2019

SELL
$180.87 - $203.88 $1.29 Million - $1.45 Million
-7,107 Reduced 5.55%
121,061 $23 Million
Q4 2018

Feb 11, 2019

SELL
$178.4 - $208.25 $3.06 Million - $3.57 Million
-17,137 Reduced 11.79%
128,168 $25 Million
Q3 2018

Oct 22, 2018

SELL
$185.29 - $208.89 $3.19 Million - $3.6 Million
-17,216 Reduced 10.59%
145,305 $30.1 Million
Q2 2018

Jul 23, 2018

SELL
$166.05 - $186.51 $1.69 Million - $1.9 Million
-10,196 Reduced 5.9%
162,521 $30 Million
Q1 2018

Apr 20, 2018

SELL
$169.43 - $198.0 $4.31 Million - $5.04 Million
-25,450 Reduced 12.84%
172,717 $29.4 Million
Q4 2017

Jan 23, 2018

SELL
$168.79 - $188.59 $683,261 - $763,412
-4,048 Reduced 2.0%
198,167 $34.5 Million
Q3 2017

Nov 13, 2017

BUY
$167.29 - $191.0 $33.8 Million - $38.6 Million
202,215
202,215 $37.7 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Texas Permanent School Fund Portfolio

Follow Texas Permanent School Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

News

Stay updated on Texas Permanent School Fund with notifications on news.